Medtech Insights

COVID-19–related delays to hip and knee replacement procedures negatively impacted the US large-joint reconstructive implant market in 2020 and into 2021; however, the market saw strong year-over…

The COVID-19 pandemic has negatively impacted the Asia Pacific biosurgical agent market due to the deferral or cancelation of elective and semi-elective procedures; however, following a period of…

The COVID-19 pandemic has had a significant impact on the Asia Pacific large-joint reconstructive implant market given that many of these procedures are considered elective. Following the…

Compared to other major orthopedic device markets, the Asia Pacific trauma device market has been somewhat less severely impacted by the COVID-19 pandemic given the urgent nature of many trauma…

Compared to other major orthopedic device markets, the Asia Pacific trauma device market has been somewhat less severely impacted by the COVID-19 pandemic given the urgent nature of many trauma…

The COVID-19 global pandemic will have a significant impact on the Asia Pacific CRM device market in the short term, resulting in lost procedure volumes; however, following a period of recovery,…

Despite the negative—albeit relatively limited—impact of the ongoing COVID-19 pandemic, the Asia Pacific interventional oncology device market will see strong growth through 2030 driven by…

Growing AF treatment volumes, driven by an expanding patient pool, rising awareness of ablation procedures, and improving access to health care, will fuel strong growth in the Asia Pacific EP …

The Asia Pacific market for CRM devices will expand through 2029, driven primarily by an aging population, the increasing prevalence of sedentary lifestyles and unhealthy diets, and the…

Despite the negative impact of the COVID-19 pandemic in the short term, the Asia-Pacific IC device market will grow modestly, driven by improving healthcare infrastructure, growing demand, and…

Although the COVID-19 pandemic will have a significant impact on the Asia Pacific aesthetic injectable market in the short term, the market will grow rapidly through 2030. Recovery of the market…

The Asia Pacific heart valve device market will experience robust growth through 2029, driven by economic expansion, an aging population, and the adoption of THV devices. However, market…